O12.4. EFFECTS OF THE GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONIST EXENATIDE ON BONE STATUS IN OBESE, NON-DIABETIC, ANTIPSYCHOTIC-TREATED SCHIZOPHRENIA SPECTRUM PATIENTS

Research output: Contribution to journalConference abstract in journalResearch

Original languageEnglish
JournalSchizophrenia Bulletin
Volume45
Issue numberSuppl. 2
Pages (from-to)S198-S199
Number of pages1
ISSN0586-7614
DOIs
Publication statusPublished - 2019

ID: 237801066